445 related articles for article (PubMed ID: 34810136)
1. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
[TBL] [Abstract][Full Text] [Related]
2. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
Aruru M; Truong HA; Clark S
Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with the intensity of government remunerated and unremunerated service provision in community pharmacies.
Czarniak P; Krass I; Sunderland B; Sim TF; Carter S
Res Social Adm Pharm; 2021 Sep; 17(9):1614-1622. PubMed ID: 33423903
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional investigation of the impact of COVID-19 on community pharmacy.
Gicic A; Li S; Amini S; Sim TF; White C; Sunderland B; Czarniak P
Explor Res Clin Soc Pharm; 2022 Jun; 6():100145. PubMed ID: 35669700
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
6. Pandemic preparedness of community pharmacies for COVID-19.
Bahlol M; Dewey RS
Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
[TBL] [Abstract][Full Text] [Related]
7. Pharmacy interventions on COVID-19 in Europe: Mapping current practices and a scoping review.
Costa S; Romão M; Mendes M; Horta MR; Rodrigues AT; Carneiro AV; Martins AP; Mallarini E; Naci H; Babar ZU
Res Social Adm Pharm; 2022 Aug; 18(8):3338-3349. PubMed ID: 34924315
[TBL] [Abstract][Full Text] [Related]
8. Emergency supply of prescription-only medicines to patients by community pharmacists: a mixed methods evaluation incorporating patient, pharmacist and GP perspectives.
Morecroft CW; Mackridge AJ; Stokes EC; Gray NJ; Wilson SE; Ashcroft DM; Mensah N; Pickup GB
BMJ Open; 2015 Jul; 5(7):e006934. PubMed ID: 26163029
[TBL] [Abstract][Full Text] [Related]
9. Non-prescription medicines: a process for standards development and testing in community pharmacy.
Benrimoj SC; Gilbert A; Quintrell N; Neto AC
Pharm World Sci; 2007 Aug; 29(4):386-94. PubMed ID: 17333499
[TBL] [Abstract][Full Text] [Related]
10. Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey.
Zaidi STR; Hasan SS
Res Social Adm Pharm; 2021 Jan; 17(1):1832-1837. PubMed ID: 33317761
[TBL] [Abstract][Full Text] [Related]
11. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
Shepherd MD
J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
[TBL] [Abstract][Full Text] [Related]
12. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective.
Zheng SQ; Yang L; Zhou PX; Li HB; Liu F; Zhao RS
Res Social Adm Pharm; 2021 Jan; 17(1):1819-1824. PubMed ID: 32249102
[TBL] [Abstract][Full Text] [Related]
13. [Changes in Attitudes to Medical Care among Pharmacy Pharmacists before and after the COVID-19 Pandemic: A Questionnaire Survey].
Norikoshi Y; Matsunaga Y; Uchida Y; Horio F; Anraku M; Suruki K; Inaba I; Nagata Y; Ikeda T
Yakugaku Zasshi; 2023; 143(12):1027-1038. PubMed ID: 38044108
[TBL] [Abstract][Full Text] [Related]
14. Discounting of medicines in Australian community pharmacies.
Thai LP; Vitry AI; Moss JR
Aust Health Rev; 2014 Nov; 38(5):517-22. PubMed ID: 25099433
[TBL] [Abstract][Full Text] [Related]
15. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
Sim TF; Hattingh HL; Sherriff J; Tee LBG
Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
[TBL] [Abstract][Full Text] [Related]
16. Nurse practitioners: an insight into their integration into Australian community pharmacies.
McMillan SS; Emmerton L
Res Social Adm Pharm; 2013; 9(6):975-80. PubMed ID: 23062783
[TBL] [Abstract][Full Text] [Related]
17. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.
Ghibu S; Juncan AM; Rus LL; Frum A; Dobrea CM; Chiş AA; Gligor FG; Morgovan C
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574698
[TBL] [Abstract][Full Text] [Related]
18. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
19. The coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 in Malaysia.
Kua KP; Lee SWH
Int J Clin Pract; 2021 Dec; 75(12):e14992. PubMed ID: 34710264
[TBL] [Abstract][Full Text] [Related]
20. Non-prescription medicines: current issues in Australian community pharmacy.
Tan AC; Emmerton L
Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
